Liguo Liu
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 29
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 5
- Vascular Tumors and Angiosarcomas 5
-
- RNA modifications and cancer 4
- Co-authors
- Xuebing Yan (11 shared papers)Qi Jin (15 shared papers)Huanlong Qin (4 shared papers)Yingbin Liu (12 shared papers)Haidong Tan (11 shared papers)Zhenliang Sun (1 shared paper)Hao Li (1 shared paper)Zhiying Yang (8 shared papers)
- Journals
- OncoTargets and Therapy (3 papers)Cancer Letters (3 papers)International Journal of Biological Sciences (2 papers)Molecular & Cellular Proteomics (2 papers)Journal of Proteomics (2 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Liguo Liu
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 103
- Oncology 432
- Cancer Research 202
- Immunology 266
- Molecular Biology 554
- Pulmonary and Respiratory Medicine 185
Countries citing papers authored by Liguo Liu
This map shows the geographic impact of Liguo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liguo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liguo Liu more than expected).
Fields of papers citing papers by Liguo Liu
This network shows the impact of papers produced by Liguo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liguo Liu. The network helps show where Liguo Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Liguo Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 165 | |
| 2 | 2017 | 91 | |
| 3 | 2021 | 85 | |
| 4 | 2019 | 51 | |
| 5 | 2014 | 40 | |
| 6 | 2012 | 39 | |
| 7 | 2023 | 36 | |
| 8 | 2023 | 33 | |
| 9 | 2021 | 32 | |
| 10 | 2013 | 30 | |
| 11 | 2020 | 28 | |
| 12 | Dual specificity phosphatase 5 is a novel prognostic indicator for patients with advanced colorectal cancer. | 2016 | 28 |
| 13 | 2022 | 27 | |
| 14 | 2017 | 26 | |
| 15 | 2018 | 23 | |
| 16 | 2016 | 23 | |
| 17 | 2023 | 22 | |
| 18 | 2013 | 22 | |
| 19 | 2020 | 22 | |
| 20 | 2019 | 22 |
About Liguo Liu
Liguo Liu is a scholar working on Oncology, Molecular Biology, Surgery, Epidemiology and Immunology, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Tuberculosis Research and Epidemiology (5 papers), Immunotherapy and Immune Responses (5 papers), Vascular Tumors and Angiosarcomas (5 papers), Cancer, Lipids, and Metabolism (4 papers), RNA modifications and cancer (4 papers) and Vascular Malformations and Hemangiomas (4 papers). The work is most often cited by research in Oncology (432 citations), Cancer Research (202 citations), Immunology (266 citations), Molecular Biology (554 citations) and Pulmonary and Respiratory Medicine (185 citations). Liguo Liu has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Xuebing Yan, Qi Jin, Huanlong Qin, Yingbin Liu, Haidong Tan, Zhenliang Sun, Hao Li, Zhiying Yang, Yijian Zhang and Chengkai Jiang. Their work appears in journals such as OncoTargets and Therapy, Cancer Letters, International Journal of Biological Sciences, Molecular & Cellular Proteomics and Journal of Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.